↓ Skip to main content

Advances in Roles of miR-132 in the Nervous System

Overview of attention for article published in Frontiers in Pharmacology, October 2017
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
92 Dimensions

Readers on

mendeley
127 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Advances in Roles of miR-132 in the Nervous System
Published in
Frontiers in Pharmacology, October 2017
DOI 10.3389/fphar.2017.00770
Pubmed ID
Authors

Yun Qian, Jialin Song, Yuanming Ouyang, Qixin Han, Wei Chen, Xiaotian Zhao, Yangmei Xie, Yinghui Chen, Weien Yuan, Cunyi Fan

Abstract

miR-132 is an endogenous small RNA and controls post-transcriptional regulation of gene expression via controlled degradation of mRNA or transcription inhibition. In the nervous system, miR-132 is significant for regulating neuronal differentiation, maturation and functioning, and widely participates in axon growth, neural migration, and plasticity. The miR-132 is affected by factors like mRNA expression, functional redundancy, and signaling cascades. It targets multiple downstream molecules to influence physiological and pathological neuronal activities. MiR-132 can influence the pathogenesis of many diseases, especially in the nervous system. The dysregulation of miR-132 results in the occurrence and exacerbation of neural developmental, degenerative diseases, like Alzheimer's disease, Parkinson's disease and epilepsy, neural infection and psychiatric disorders including disturbance of consciousness, cognition and memory, depression and schizophrenia. Regulation of miR-132 expression relieves symptoms, alleviates severity and finally effects a cure. This review aims to discuss the clinical potentials of miR-132 in the nervous system.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 127 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 127 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 23 18%
Student > Bachelor 17 13%
Researcher 14 11%
Other 10 8%
Student > Master 9 7%
Other 14 11%
Unknown 40 31%
Readers by discipline Count As %
Biochemistry, Genetics and Molecular Biology 30 24%
Neuroscience 19 15%
Agricultural and Biological Sciences 8 6%
Medicine and Dentistry 8 6%
Pharmacology, Toxicology and Pharmaceutical Science 4 3%
Other 14 11%
Unknown 44 35%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 October 2017.
All research outputs
#22,808,451
of 25,432,721 outputs
Outputs from Frontiers in Pharmacology
#12,432
of 19,772 outputs
Outputs of similar age
#297,154
of 338,297 outputs
Outputs of similar age from Frontiers in Pharmacology
#167
of 276 outputs
Altmetric has tracked 25,432,721 research outputs across all sources so far. This one is in the 1st percentile – i.e., 1% of other outputs scored the same or lower than it.
So far Altmetric has tracked 19,772 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 5.3. This one is in the 1st percentile – i.e., 1% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 338,297 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 276 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.